NFATC2 and myeloid sarcoma: Comparison of the NFATc2 expression level in the two study groups showed an up-regulation in NFATc2 mRNA level in the MS versus control groups by 275% ± 0.4586 (Pvalue = 0.0019) (Fig. 2B).